HopeStage
Back to all studies
CompletedNCT01689909

Zolpidem or Placebo for Insomnia and Suicidal Thoughts in Depression

About this titleRead the official source — NCT01689909
Medication studyAges 18–65United StatesSuicide prevention
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Augusta and 3 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 6, 2012
Recruitment status
Completed
Enrollment listed in the registry
103
Sponsor
Augusta University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01689909
Official title
Show the full official title

Reducing Suicidal Ideation Through Insomnia Treatment

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Augusta · Durham · Wake Forest

1 more locations
  • Madison

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Augusta University, a university.

Did this study involve medication?

Yes. The study involved medication, including Zolpidem-CR and Placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies